FDA TO HOLD ODAC MEETING MARCH 13, 2008 TO RECONSIDER ESA USE BY CANCER PATIENTS The FDA will hold a meeting of its Oncologic Drugs Advisory Committee on March 13 to further consider issues and information about ESA use and safety. The meeting will be held from 8:00 a.m. until 4:00 p.m. at the Holiday Inn in Gaithersburg, Maryland. You can find additional information about this public meeting here: ODAC MEETING INFORMATION. Note that if you wish to speak during the public hearing portion of this advisory committee meeting, you must notify the FDA within seven days of the meeting. The contact information is provided in the above link.